Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2010 (2010), Article ID 370692, 4 pages
http://dx.doi.org/10.1155/2010/370692
Case Report

Spuriously Elevated Serum IGF-1 in Adult Individuals with Delayed Puberty: A Diagnostic Pitfall

1Division of Endocrinology & Metabolism, Dalhousie University, Halifax, NS, Canada B3H 3J5
2Divisions of Endocrinology & Metabolism & Neurosurgery, Halifax Neuropituitary Program, 7th Floor N, VG Site, 1278 Tower Road, Halifax, NS, Canada B3H 2Y9
3Division of Endocrinology, The University of Manchester, Manchester M13 9PL, UK
4Division of Endocrinology, University of Toronto, Toronto, ON, Canada M5S 1A1

Received 25 May 2010; Revised 9 June 2010; Accepted 9 August 2010

Academic Editor: Ariel L. Barkan

Copyright © 2010 Syed Ali Imran et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. R. Clemmons, J. J. Van Wyk, E. C. Ridgway et al., “Evaluation of acromegaly by radioimmunoassay of somatomedin-C,” The New England Journal of Medicine, vol. 301, no. 21, pp. 1138–1142, 1979. View at Google Scholar · View at Scopus
  2. A. Juul, “Serum levels of insulin-like growth factor I and its binding proteins in health and disease,” Growth Hormone and IGF Research, vol. 13, no. 4, pp. 113–170, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. A. J. Whatmore, C. M. Hall, J. Jones, M. Westwood, and P. E. Clayton, “Ghrelin concentrations in healthy children and adolescents,” Clinical Endocrinology, vol. 59, no. 5, pp. 649–654, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. G. D. Eakman, J. S. Dallas, S. W. Ponder, and B. S. Keenan, “The effects of testosterone and dihydrotestosterone on hypothalamic regulation of growth hormone secretion,” Journal of Clinical Endocrinology and Metabolism, vol. 81, no. 3, pp. 1217–1223, 1996. View at Publisher · View at Google Scholar · View at Scopus
  5. B. Stoffel-Wagner, W. Springer, F. Bidlingmaier, and D. Klingmüller, “A comparison of different methods for diagnosing acromegaly,” Clinical Endocrinology, vol. 46, no. 5, pp. 531–537, 1997. View at Google Scholar · View at Scopus
  6. R. C. Baxter, S. Brown, and J. R. Turtle, “Radioimmunoassay for somatomedin C: comparison with radioreceptor assay in patients with growth-hormone disorders, hypothyroisism, and renal failure,” Clinical Chemistry, vol. 28, no. 3, pp. 488–495, 1982. View at Google Scholar · View at Scopus
  7. M. E. Street, G. De'Angelis, C. Camacho-Hübner et al., “Relationships between serum IGF-1, IGFBP-2, interleukin-1beta and interleukin-6 in inflammatory bowel disease,” Hormone Research, vol. 61, no. 4, pp. 159–164, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. E. Alsat, J. Guibourdenche, D. Luton, F. Frankenne, and D. Evain-Brion, “Human placental growth hormone,” American Journal of Obstetrics and Gynecology, vol. 177, no. 6, pp. 1526–1534, 1997. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Frystyk, “Free insulin-like growth factors—measurements and relationships to growth hormone secretion and glucose homeostasis,” Growth Hormone and IGF Research, vol. 14, no. 5, pp. 337–375, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. R. Lanzi, L. Luzi, A. Caumo et al., “Elevated insulin levels contribute to the reduced growth hormone (GH) response to GH-releasing hormone in obese subjects,” Metabolism, vol. 48, no. 9, pp. 1152–1156, 1999. View at Publisher · View at Google Scholar · View at Scopus
  11. J. M. Gómez, F. J. Maravall, N. Gómez, M. Á. Navarro, R. Casamitjana, and J. Soler, “The IGF-I system component concentrations that decrease with ageing are lower in obesity in relationship to body mass index and body fat,” Growth Hormone and IGF Research, vol. 14, no. 2, pp. 91–96, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. J. W. Finkelstein, H. P. Roffwarg, R. M. Boyar, J. Kream, and L. Hellman, “Age-related change in the twenty-four-hour spontaneous secretion of growth hormone,” Journal of Clinical Endocrinology and Metabolism, vol. 35, no. 5, pp. 665–670, 1972. View at Google Scholar · View at Scopus
  13. A. Juul, P. Bang, N. T. Hertel et al., “Serum insulin-like growth factor-I in 1030 healthy children, adolescents, and adults: relation to age, sex, stage of puberty, testicular size, and body mass index,” Journal of Clinical Endocrinology and Metabolism, vol. 78, no. 3, pp. 744–752, 1994. View at Publisher · View at Google Scholar · View at Scopus
  14. A. M. Luna, D. M. Wilson, C. J. Wibbeanlsman et al., “Somatomedins in adolescence: a cross-sectional study of the effect of puberty on plasma insulin-like growth factor I and II levels,” Journal of Clinical Endocrinology and Metabolism, vol. 57, no. 2, pp. 268–271, 1983. View at Google Scholar · View at Scopus
  15. N. Kanbur-Öksüz, O. Derman, and E. Kinik, “Correlation of sex steroids with IGF-1 and IGFBP-3 during different pubertal stages,” Turkish Journal of Pediatrics, vol. 46, no. 4, pp. 315–321, 2004. View at Google Scholar · View at Scopus
  16. J. S. Cook, R. P. Hoffman, M. A. Stene, and J. R. Hansen, “Effects of maturational stage on insulin sensitivity during puberty,” Journal of Clinical Endocrinology and Metabolism, vol. 77, no. 3, pp. 725–730, 1993. View at Publisher · View at Google Scholar · View at Scopus
  17. R. I. Rosenfield, R. Furlanetto, and D. Bock, “Relationship of somatomedin-C concentrations to pubertal changes,” Journal of Pediatrics, vol. 103, no. 5, pp. 723–728, 1983. View at Google Scholar · View at Scopus
  18. D. A. Harris, G. Van Vliet, C. A. Egli et al., “Somatomedin-C in normal puberty and in true precocious puberty before and after treatment with a potent luteinizing hormone-releasing hormone agonist,” Journal of Clinical Endocrinology and Metabolism, vol. 61, no. 1, pp. 152–159, 1985. View at Google Scholar · View at Scopus
  19. G. W. Moll Jr., R. L. Rosenfield, and V. S. Fang, “Administration of low-dose estrogen rapidly and directly stimulates growth hormone production,” American Journal of Diseases of Children, vol. 140, no. 2, pp. 124–127, 1986. View at Google Scholar · View at Scopus
  20. R. L. Rosenfield and R. Furlanetto, “Physiologic testosterone or estradiol induction of puberty increases plasma somatomedin-C,” Journal of Pediatrics, vol. 107, no. 3, pp. 415–417, 1985. View at Google Scholar · View at Scopus
  21. B. S. Keenan, G. E. Richards, S. W. Ponder, J. S. Dallas, M. Nagamani, and E. R. Smith, “Androgen-stimulated pubertal growth: the effects of testosterone and dihydrotestosterone on growth hormone and insulin-like growth factor-I in the treatment of short stature and delayed puberty,” Journal of Clinical Endocrinology and Metabolism, vol. 76, no. 4, pp. 996–1001, 1993. View at Publisher · View at Google Scholar · View at Scopus
  22. W. H. Craft and L. E. Underwood, “Effect of androgens on plasma somatomedin-C/insulin-like growth factor I responses to growth hormone,” Clinical Endocrinology, vol. 20, no. 5, pp. 549–554, 1984. View at Google Scholar · View at Scopus